You're not (at least that we've found).

Agree it's a powerhouse team and backing, but HRS9531 (Kailera's lead program) isn't even close to best-in-class. Based on the human clinical data so far it'll be 4th place when approved, and competing with a better generic by 2032.

If anyone is interested in going this direction in their research feel free to reach out, I'm happy to discuss or brainstorm what kind of experiments could come next!

In those animals we didn't observe a correlation between ripples and glucose fluctuations. To me, this strongly suggested pancreatic insulin release is a mechanistic intermediate

Wow, thanks so much Adrien! It was such an exciting project to work on, and many directions to follow up. Another *really hidden gem (it didn't end up in the paper), we (@jocarpenter and I) treated three rats with streptozotocin which effectively kills beta cells in the pancreas...

Could I get added?

Any chance I could get added? This was super helpful for finding everyone, thanks!

I'd read that paper